raw shard 360
Browse files- raw/shard_00360.jsonl +5 -0
raw/shard_00360.jsonl
ADDED
|
@@ -0,0 +1,5 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
{"session_id": "atlas-d555a8f0ef", "tier": "text", "task_instruction": "Determine how leukemia is diagnosed and classified.", "source": "llm_generated", "grounded_in": "wikitext-103", "steps": [{"step_index": 0, "observation": {"text": "The passage mentions that marrow or blood samples are examined under light microscopy.", "image_path": null, "audio_path": null}, "reasoning": "This method helps visualize the cells' structure, aiding in the initial diagnosis of leukemia.", "action": {"type": "text_response", "value": "Recognize light microscopy as a primary diagnostic tool."}, "refers_back_to": null}, {"step_index": 1, "observation": {"text": "Flow cytometry is also used in the diagnosis.", "image_path": null, "audio_path": null}, "reasoning": "It aids in distinguishing different leukemia types by analyzing cell characteristics.", "action": {"type": "text_response", "value": "Identify flow cytometry for differentiation purposes."}, "refers_back_to": null}, {"step_index": 2, "observation": {"text": "Cytogenetics and FISH are employed to detect chromosomal abnormalities.", "image_path": null, "audio_path": null}, "reasoning": "These abnormalities are crucial for determining the subtype and prognosis.", "action": {"type": "text_response", "value": "Note the use of cytogenetics and FISH for chromosomal analysis."}, "refers_back_to": null}, {"step_index": 3, "observation": {"text": "Genetic studies are conducted to identify specific mutations in certain genes.", "image_path": null, "audio_path": null}, "reasoning": "These mutations can affect treatment plans and disease outcome.", "action": {"type": "text_response", "value": "Highlight genetic testing for mutations influencing prognosis."}, "refers_back_to": null}], "task_complexity": "low", "language": "en", "license": "CC-BY-SA-3.0", "date_created": "2026-08-17", "_structural_pass": true, "_structural_reason": "ok", "_repaired": false, "_seed_type": "wikitext", "_seed_content": "Marrow or blood is examined under light microscopy , as well as flow cytometry , to diagnose the presence of leukemia , to differentiate AML from other types of leukemia ( e.g. acute lymphoblastic leukemia - ALL ) , and to classify the subtype of disease . A sample of marrow or blood is typically also tested for chromosomal abnormalities by routine cytogenetics or fluorescent in situ hybridization . Genetic studies may also be performed to look for specific mutations in genes such as FLT3 , nucleophosmin , and KIT , which may influence the outcome of the disease ."}
|
| 2 |
+
{"session_id": "atlas-77793acba4", "tier": "text", "task_instruction": "Determine the appropriate cytochemical stains needed for differentiating AML from ALL and subclassifying AML.", "source": "llm_generated", "grounded_in": "wikitext-103", "steps": [{"step_index": 0, "observation": {"text": "The passage discusses the use of cytochemical stains in distinguishing AML from ALL and subclassifying AML.", "image_path": null, "audio_path": null}, "reasoning": "I need to identify which specific cytochemical stains are mentioned for these purposes.", "action": {"type": "text_response", "value": "Identify the specific stains mentioned in the passage."}, "refers_back_to": null}, {"step_index": 1, "observation": {"text": "The passage mentions a combination of myeloperoxidase or Sudan black stain and a nonspecific esterase stain.", "image_path": null, "audio_path": null}, "reasoning": "These two stains are used together because myeloperoxidase or Sudan black helps establish the identity of AML and distinguish it from ALL, while the nonspecific esterase stain helps identify a monocytic component in AMLs and differentiate poorly differentiated monoblastic leukemia from ALL.", "action": {"type": "text_response", "value": "List the two specific cytochemical stains and their respective roles."}, "refers_back_to": null}], "task_complexity": "low", "language": "en", "license": "CC-BY-SA-3.0", "date_created": "2026-08-17", "_structural_pass": true, "_structural_reason": "ok", "_repaired": false, "_seed_type": "wikitext", "_seed_content": "Cytochemical stains on blood and bone marrow smears are helpful in the distinction of AML from ALL , and in subclassification of AML . The combination of a myeloperoxidase or Sudan black stain and a nonspecific esterase stain will provide the desired information in most cases . The myeloperoxidase or Sudan black reactions are most useful in establishing the identity of AML and distinguishing it from ALL . The nonspecific esterase stain is used to identify a monocytic component in AMLs and to distinguish a poorly differentiated monoblastic leukemia from ALL ."}
|
| 3 |
+
{"session_id": "atlas-0143717e41", "tier": "text", "task_instruction": "Determine the difficulty level of diagnosing AML based on the presence of specific morphological features and flow cytometry results.", "source": "llm_generated", "grounded_in": "wikitext-103", "steps": [{"step_index": 0, "observation": {"text": "The passage discusses the diagnosis and classification of AML.", "image_path": null, "audio_path": null}, "reasoning": "AML is a type of leukemia that can be challenging to diagnose, especially without specific features like Auer rods or flow cytometry results.", "action": {"type": "text_response", "value": "I need to determine if the presence of these features makes diagnosis easier or harder."}, "refers_back_to": null}, {"step_index": 1, "observation": {"text": "In straightforward cases, certain morphologic features or flow cytometry results can distinguish AML from other leukemias.", "image_path": null, "audio_path": null}, "reasoning": "When these features are present, the diagnosis is more straightforward because they help differentiate AML from other leukemias.", "action": {"type": "text_response", "value": "This suggests that the presence of such features makes the diagnosis easier."}, "refers_back_to": null}, {"step_index": 2, "observation": {"text": "However, in the absence of such features, diagnosis becomes more difficult.", "image_path": null, "audio_path": null}, "reasoning": "Without these specific features, it's harder to distinguish AML from other leukemias, increasing the difficulty of diagnosis.", "action": {"type": "text_response", "value": "Therefore, the difficulty level of diagnosis varies depending on the presence of these features."}, "refers_back_to": null}], "task_complexity": "low", "language": "en", "license": "CC-BY-SA-3.0", "date_created": "2026-08-17", "_structural_pass": true, "_structural_reason": "ok", "_repaired": false, "_seed_type": "wikitext", "_seed_content": "The diagnosis and classification of AML can be challenging , and should be performed by a qualified hematopathologist or hematologist . In straightforward cases , the presence of certain morphologic features ( such as Auer rods ) or specific flow cytometry results can distinguish AML from other leukemias ; however , in the absence of such features , diagnosis may be more difficult ."}
|
| 4 |
+
{"session_id": "atlas-c5a029d0dd", "tier": "text", "task_instruction": "Determine the correct blast percentage threshold for diagnosing AML according to both the FAB and WHO classification systems.", "source": "llm_generated", "grounded_in": "wikitext-103", "steps": [{"step_index": 0, "observation": {"text": "The passage discusses two classification systems for AML: FAB and WHO.", "image_path": null, "audio_path": null}, "reasoning": "I need to compare the diagnostic criteria for AML under both systems.", "action": {"type": "text_response", "value": "Identify the key diagnostic thresholds mentioned for each system."}, "refers_back_to": null}, {"step_index": 1, "observation": {"text": "The WHO system requires a blast percentage of more than 20% in blood or bone marrow.", "image_path": null, "audio_path": null}, "reasoning": "However, this threshold is excepted for three specific genetic abnormalities where the presence of the genetic abnormality is diagnostic regardless of blast percentage.", "action": {"type": "text_response", "value": "Note that the 20% threshold is standard for most cases under WHO."}, "refers_back_to": null}, {"step_index": 2, "observation": {"text": "The FAB classification is more stringent, requiring at least 30% blast percentage in bone marrow or peripheral blood.", "image_path": null, "audio_path": null}, "reasoning": "This means FAB requires a higher threshold than WHO for most cases.", "action": {"type": "text_response", "value": "Compare the two thresholds: WHO at >20% and FAB at ≥30%."}, "refers_back_to": null}, {"step_index": 3, "observation": {"text": "AML must be differentiated from preleukemic conditions, which have different treatment approaches.", "image_path": null, "audio_path": null}, "reasoning": "This differentiation is crucial but doesn't affect the blast percentage thresholds for AML diagnosis.", "action": {"type": "text_response", "value": "Focus solely on the blast percentage criteria for the task."}, "refers_back_to": null}], "task_complexity": "high", "language": "en", "license": "CC-BY-SA-3.0", "date_created": "2026-08-17", "_structural_pass": true, "_structural_reason": "ok", "_repaired": false, "_seed_type": "wikitext", "_seed_content": "The two most commonly used classification schemata for AML are the older French @-@ American @-@ British ( FAB ) system and the newer World Health Organization ( WHO ) system . According to the widely used WHO criteria , the diagnosis of AML is established by demonstrating involvement of more than 20 % of the blood and / or bone marrow by leukemic myeloblasts , except in the three best prognosis forms of AML with recurrent genetic abnormalities ( t ( 8 ; 21 ) , inv ( 16 ) , and t ( 15 ; 17 ) ) in which the presence of the genetic abnormality is diagnostic irrespective of blast percent . The French – American – British ( FAB ) classification is a bit more stringent , requiring a blast percentage of at least 30 % in bone marrow ( BM ) or peripheral blood ( PB ) for the diagnosis of AML . AML must be carefully differentiated from \" preleukemic \" conditions such as myelodysplastic or myeloproliferative syndromes , which are treated differently ."}
|
| 5 |
+
{"session_id": "atlas-6875107e6d", "tier": "text", "task_instruction": "Determine the most appropriate diagnostic method for acute promyelocytic leukemia (APL)", "source": "llm_generated", "grounded_in": "wikitext-103", "steps": [{"step_index": 0, "observation": {"text": "APL requires a unique treatment and has the highest curability, so accurate diagnosis is crucial.", "image_path": null, "audio_path": null}, "reasoning": "Given that APL has the highest curability and requires specific treatment, it's essential to diagnose it accurately and quickly. This means the diagnostic method must be both efficient and precise to ensure timely and correct treatment initiation.", "action": {"type": "text_response", "value": "Identify a diagnostic method that is both efficient and precise for APL."}, "refers_back_to": null}, {"step_index": 1, "observation": {"text": "Fluorescent in situ hybridization (FISH) is used on blood or bone marrow samples to detect the specific chromosomal translocation [t(15;17)(q22;q12)] associated with APL.", "image_path": null, "audio_path": null}, "reasoning": "FISH is highlighted as a method that can quickly and accurately identify the chromosomal translocation that is characteristic of APL. This makes it a suitable choice for diagnosis as it provides a clear and specific indicator of the disease.", "action": {"type": "text_response", "value": "Consider FISH as a primary diagnostic tool."}, "refers_back_to": null}, {"step_index": 2, "observation": {"text": "The presence of the PML/RARA fusion protein, which is an oncogenic product of the translocation, needs to be molecularly detected.", "image_path": null, "audio_path": null}, "reasoning": "The passage mentions that molecular detection of the PML/RARA fusion protein is necessary. This protein is a direct result of the chromosomal translocation and serves as an oncogenic factor in APL. Therefore, confirming the presence of this protein is crucial for diagnosis.", "action": {"type": "text_response", "value": "Include molecular testing for the PML/RARA fusion protein in the diagnostic process."}, "refers_back_to": null}, {"step_index": 3, "observation": {"text": "FISH can identify the chromosomal translocation that leads to the PML/RARA fusion protein.", "image_path": null, "audio_path": null}, "reasoning": "Since FISH identifies the chromosomal abnormality responsible for the PML/RARA fusion, it effectively confirms the presence of the fusion protein. Therefore, FISH is sufficient for diagnosis, though molecular testing can serve as a confirmatory step if needed.", "action": {"type": "text_response", "value": "Recommend FISH as the primary diagnostic method, with molecular testing as an additional confirmatory step if required."}, "refers_back_to": null}], "task_complexity": "high", "language": "en", "license": "CC-BY-SA-3.0", "date_created": "2026-08-17", "_structural_pass": true, "_structural_reason": "ok", "_repaired": false, "_seed_type": "wikitext", "_seed_content": "Because acute promyelocytic leukemia ( APL ) has the highest curability and requires a unique form of treatment , it is important to quickly establish or exclude the diagnosis of this subtype of leukemia . Fluorescent in situ hybridization performed on blood or bone marrow is often used for this purpose , as it readily identifies the chromosomal translocation [ t ( 15 ; 17 ) ( q22 ; q12 ) ; ] that characterizes APL . There is also a need to molecularly detect the presence of PML / RARA fusion protein , which is an oncogenic product of that translocation ."}
|